EP Patent

EP3977985B1 — Compositions comprising pgi2-receptor agonists and processes for the preparation thereof

Assigned to Arena Pharmaceuticals Inc · Expires 2023-09-06 · 3y expired

What this patent protects

Patent listed against Uptravi.

Drugs covered by this patent

Patent Metadata

Patent number
EP3977985B1
Jurisdiction
EP
Classification
—
Expires
2023-09-06
Drug substance claim
No
Drug product claim
No
Assignee
Arena Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.